FTI Consulting boosts life sciences arm with Brett Pollard appointment

FTI Consulting has appointed scientist and analyst Dr Brett Pollard as a senior director in its life sciences team.

Pollard has been in the healthcare industry for more than 15 years, initially as an equity analyst. He co-founded Abingdon Health in 2008 and was previously head of life science research at Numis. Pollard also spent time at Seymour-Pierce and Deutsche Bank and has a PhD in Molecular Virology and a BSc in Cell and Molecular Biology.

FTI said its life sciences arm has advised on 16 M&A deals since the start of 2014, worth more than $100bn (£65bn), and has advised on eight stock market flotations.

Ben Atwell, senior MD and head of FTI’s life sciences team, said: "We are very pleased that Brett is joining us and believe his deep experience from a range of different roles within the healthcare industry will benefit our clients and our established team of industry experts."

Pollard said: "I’ve worked with FTI as an analyst and as a client and believe that the team is the clear market leader in the life sciences sector in London. I am looking forward to helping strengthen and extend this leadership."

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in

Would you like to post a comment?

Please Sign in or register.